BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Paradigm Medical Industries To Introduce Several New Instruments At AAO Convention

  October 4, 2006

   · 

  1 min read
• Deals

  Asthmatx, Inc. Sets IPO At 5 Million Shares, $11-$13 Each

  October 4, 2006

   · 

  1 min read
• Genetown

  Dynogen Pharmaceuticals, Inc. Awarded U.S. Patent For Use Of DDP225 In Overactive Bladder

  October 4, 2006

   · 

  1 min read
• FDA

  Health Canada Grants Approval Of TYSABRI(TM) (natalizumab) For The Treatment Of Multiple Sclerosis Following Priority Review

  October 4, 2006

   · 

  1 min read
• Business

  ATS Medical, Inc. Announces Vice President Of Research And Development

  October 4, 2006

   · 

  3 min read
• Genetown

  Alnylam Pharmaceuticals Notified of Defense Appropriation Funding For Ongoing Development Of RNAi Therapeutics

  October 4, 2006

   · 

  1 min read
• Drug Development

  Phoqus Limited Aims To Raise 3 Mln Stg In Placing

  October 4, 2006

   · 

  1 min read
• Business

  CELLECTIS SA Appoints Marc Le Bozec As Chief Financial Officer

  October 4, 2006

   · 

  1 min read
• Business

  Antares Pharma, Inc. To Supply Teva Pharmaceutical Industries Limited With Innovative Needle-Free Injection System

  October 4, 2006

   · 

  1 min read
• Genetown

  Pressure BioSciences, Inc. Announces Award Of National Institutes of Health (NIH) Grant

  October 4, 2006

   · 

  1 min read